STEMLINE THERAPEUTICS INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015
Revenue
Product revenue, net
Grant income
Total revenue
Operating expenses:
Cost of goods sold
Research and development
Selling, general and administrative
Total operating expenses
Loss from operations
Other expense, net
Interest expense
Income tax expense
Net loss before income taxes
Income tax benefit
Net loss
Net loss per common share:
Basic and diluted net loss per share (in dollars per share)
Weighted-average shares outstanding:
Basic and Diluted (in shares)

Comments